{"id":115022,"date":"2020-11-30T11:56:35","date_gmt":"2020-11-30T11:56:35","guid":{"rendered":"http:\/\/ccs-website-wordpress.ind.ninja\/?page_id=115022"},"modified":"2024-02-15T17:00:52","modified_gmt":"2024-02-15T22:00:52","slug":"guidelines-and-clinical-practice-update-library","status":"publish","type":"page","link":"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/","title":{"rendered":"Guidelines and Clinical Practice Update Library"},"content":{"rendered":"\n

These statements were developed following a thorough consideration of medical literature and the best available evidence and clinical experience. They represent the consensus of a multidisciplinary panel comprised of experts on the topic with a mandate to formulate disease-specific recommendations. Recommendations are aimed to provide a reasonable and practical approach to care for specialists and allied health professionals obliged with the duty of bestowing optimal care to patients and families, and can be subject to change as scientific knowledge and technology advance and as practice patterns evolve. These statements are not intended to be a substitute for physicians using their individual judgement in managing clinical care in consultation with the patient, with appropriate regard to all the individual circumstances of the patient, diagnostic and treatment options available and available resources. Adherence to these recommendations will not necessarily produce successful outcomes in every case.<\/p>\n\n\n\n

Topic<\/th>Year<\/th>Title<\/th>Type<\/th>COI<\/th><\/tr><\/thead>
CCS Guidelines on the Fitness to Drive<\/td>Article in Press<\/td>Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive<\/a><\/td>Guideline<\/td><\/td><\/tr>
Antiplatelet Therapy<\/td>Article in Press<\/td>Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>

Team Model and Care Pathways for Aortic Disease<\/td>		2023<\/td>The Aortic Team Model and Collaborative Decision Pathways for the Management of Complex Aortic Disease: Clinical Practice Update From the Canadian Cardiovascular Society\/Canadian Society of Cardiac Surgeons\/Canadian Society for Vascular Surgery\/Canadian Association for Interventional Radiology<\/a><\/td>Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
Prolonged QT Interval<\/td>2023<\/td>2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval<\/a><\/td>Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
HF Phenotypes<\/td>2023<\/td>Canadian Cardiovascular Society-Canadian Heart Failure Society Focused Clinical
Practice Update of Patients With Differing Heart Failure Phenotypes<\/a><\/td>		Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
Neuroprognostication<\/td>2023<\/td>Neuroprognostication in the Post Cardiac Arrest Patient: A Canadian Cardiovascular Society Position Statement<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Pediatric Dyslipidemia<\/td>2022<\/td>The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society\/Canadian Pediatric Cardiology Association Clinical Practice Update<\/a><\/td>Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
Cardiorenal<\/td>2022<\/td>2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Peripheral Arterial Disease<\/td>2022<\/td>Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2022<\/td>Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults with Congenital Heart Disease<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2021<\/td>CCS: Clinical Practice Update on Cardiovascular Management of the Pregnant Patient<\/a><\/td>Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
Imaging\/Device Therapy<\/td>2021<\/td>2021 Update on the Safety of Magnetic Resonance Imaging: a Joint Position Statement from the CCS\/CanSCMR\/CHRS<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Heart Failure<\/td>2021<\/td>CCS\/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for HFrEF<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Dyslipidemia<\/td>2021<\/td>2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Atrial Fibrillation<\/td>2020<\/td>2020 CCS\/CHRS Comprehensive Guidelines for the Management of Atrial Fibrillation<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Arrhythmia<\/td>2020<\/td>2020 CCS\/CHRS Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients with Structural Heart Disease<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2020<\/td>CCS Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Heart Failure<\/td>2020<\/td>CCS\/CHFS Joint Position Statement on the Evaluation and Management of Patients with Cardiac Amyloidosis<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Heart Failure<\/td>2020<\/td>CCS Heart Failure Guidelines Update: Focus on FMR, SGLT2 Inhibitors, ARNI in HFpEF, and Amyloidosis<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Prevention \/ Risk<\/td>2020<\/td>CCS\/CTS Position Statement on Pulmonary Hypertension<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Syncope<\/td>2020<\/td>CCS Clinical Practice Update on the Assessment and Management of Syncope<\/a><\/td>Clinical Practice Update<\/td>View<\/a><\/td><\/tr>
Transplantation<\/td>2020<\/td>CCS\/CCTN Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
CAD\/ACS<\/td>2019<\/td>2019 Canadian Cardiovascular Society\/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2019<\/td>2019 CCS Position Statement for Transcatheter Aortic Valve Implantation<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Antiplatelet Therapy<\/td>2018<\/td>2018 CCS\/CAIC Focused Update of the Guidelines for the use of Antiplatelet Therapy<\/a><\/td>Guideline<\/td>View<\/a><\/td><\/tr>
Atrial Fibrillation<\/td>2018<\/td>2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation<\/a>
Supplementary Material<\/em>: Management of Atrial Fibrillation: Complete CCS Guidelines Listing<\/a><\/td>		Guideline<\/td>View<\/a><\/td><\/tr>
Dyslipidemia<\/td>2018<\/td>Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Prevention \/ Risk<\/td>2018<\/td>Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes<\/a><\/td>Position Statement<\/td>View<\/a><\/td><\/tr>
Heart Failure<\/td>2017<\/td>2017 Comprehensive Update of the CCS Guidelines for the Management of Heart Failure<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2016<\/td>Supplementary Material: Complete Guidelines Listing – 2010 to 2016<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2016<\/td>The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the CCS Guidelines<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2016<\/td>2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation<\/a>
Corrigendum:\u2005Published\u2005online\u2005November\u200529,\u20052016<\/a><\/td>		Guideline<\/td> <\/td><\/tr>
Cardiac Arrest<\/td>2016<\/td>Canadian Cardiovascular Society\/Canadian Cardiovascular Critical Care Society\/Canadian Association of Interventional Cardiology Position Statement on the Optimal Care of the Post Arrest Patient<\/a><\/td>Position Statment<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2016<\/td>Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Device Therapy<\/td>2016<\/td>CCS\/CHRS 2016 Implantable Cardioverter-Defibrillator (ICD) Guidelines<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2016<\/td>2016 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult<\/a>
Application of GRADE and Evidence Review<\/a><\/td>		Guideline<\/td> <\/td><\/tr>
Heart Disease<\/td>2016<\/td>CCS\/CPCA Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Perioperative<\/td>2016<\/td>CCS guidelines on perioperative cardiac risk assessment and management for patients undergoing noncardiac surgery<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Syncope<\/td>2016<\/td>CCS and CPCA Position Statement on the Approach to Syncope in the Pediatric Patient<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Thoracic Aortic Disease<\/td>2016<\/td>CCS\/CSCS\/CSVS Position Statement on Open and Endovascular Surgery for Thoracic Aortic Disease<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2015<\/td>The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the CCS Guidelines<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Heart Failure<\/td>2015<\/td>The CCS Heart Failure Companion: Bridging Guidelines to your Practice<\/a>
Supplementary Material:<\/em> Survey\u2005for\u2005Practical\u2005HF Guidelines\u2005Implementations\u2005by\u2005Canadian\u2005Experts<\/a><\/td>		Commentary<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2014<\/td>Supplementary Material: Complete Guidelines Listing – 2010 to 2014<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2014<\/td>Atrial Fibrillation Guidelines 2014 Focused Update: Management of Atrial Fibrillation<\/a>
Errata<\/em>: Published online June 15 2015<\/a>, Published in issue: December 2014<\/a><\/td>		Guideline<\/td> <\/td><\/tr>
CAD\/ACS<\/td>2014<\/td>Revascularization\u2014Multivessel Coronary Artery Disease – A CCS\/CAIC\/CSCS Joint Position Statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2014<\/td>Stable Ischemic Heart Disease Guidelines for Diagnosis and Management<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2014<\/td>Familial Hypercholesterolemia: CCS Position Statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2014<\/td>Are the ACC\/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Heart Failure<\/td>2014<\/td>Heart Failure Guidelines 2014 Update: Focus on Anemia, Biomarkers, and Recent Therapeutic Trial Implications<\/a>
Erratum<\/em>: Published online August 27 2015<\/a><\/td>		Guideline<\/td> <\/td><\/tr>
Thoracic Aortic Disease<\/td>2014<\/td>Management of Thoracic Aortic Disease<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Device Therapy<\/td>2013<\/td>Cardiac Resynchronization Therapy Guidelines: Implementation<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Device Therapy<\/td>2013<\/td>Use of Remote Monitoring for Cardiovascular Implantable Electronic Device Follow-up – A Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Joint Position Statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Heart Failure<\/td>2013<\/td>Heart Failure Guidelines 2013 Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2013<\/td>Radiation Exposure From Cardiac Imaging and Interventional Procedures<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Angina<\/td>2012<\/td>Management of Patients With Refractory Angina – A Canadian Cardiovascular Society\/Canadian Pain Society Joint Guidelines<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Antiplatelet Therapy<\/td>2012<\/td>Antiplatelet Therapy Guidelines 2012 Update: The Use of Antiplatelet Therapy<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Assessment to Drive\/Fly<\/td>2012<\/td>Fitness to Drive and Fly Guidelines 2012 Update: Fitness Following Left Ventricular Assist Device Implantation<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2012<\/td>Atrial Fibrillation Guidelines 2012 Update: Recommendations for Stroke Prevention and Rate\/Rhythm Control<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2012<\/td>Transcatheter Aortic Valve Implantation<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Device Therapy<\/td>2012<\/td>Cardiac Resynchronization Therapy Guidelines: Evidence and Patient Selection<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Device Therapy<\/td>2012<\/td>Perioperative Management of Patients With Implanted Pacemakers, Defibrillators, and Neurostimulating Devices – Canadian Cardiovascular Society\/Canadian Anesthesiologists’ Society\/Canadian Heart Rhythm Society Joint Position Statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2012<\/td>Dyslipidemia Guidelines 2012 Update: Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Heart Failure<\/td>2012<\/td>Heart Failure Guidelines 2012 Update: Focus on Acute and Chronic Heart Failure<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Paediatric Cardiology<\/td>2012<\/td>Presentation, Diagnosis, and Medical Management of Heart Failure in Children<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Arrhythmia<\/td>2011<\/td>Genetic Testing in the Clinical Evaluation of Inherited Cardiac Arrhythmias Associated with Sudden Cardiac Death – A Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Joint Position Paper<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Heart Failure<\/td>2011<\/td>Heart Failure Guidelines 2011 Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Prevention \/ Risk<\/td>2011<\/td>Smoking Cessation and the Cardiovascular Specialist<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Rehabilitation<\/td>2011<\/td>Systematizing Inpatient Referral to Cardiac Rehabilitation 2010 – A Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint Position Paper<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Syncope<\/td>2011<\/td>Standardized Approaches to the Investigation of Syncope<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Adult
Echocardiography<\/td>		2010<\/td>Echocardiography Guidelines for Training and Maintenance of Competency in Adult Echocardiography<\/a><\/td>Training and MOC<\/td> <\/td><\/tr>
Adult
Echocardiography<\/td>		2010<\/td>Echocardiography Guidelines for Training and Maintenance of Competency in Adult Echocardiography<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Antiplatelet Therapy<\/td>2010<\/td>Antiplatelet Therapy Guidelines 2010: The Use of Antiplatelet Therapy in the Outpatient Setting<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #5: Catheter Ablation for Atrial Fibrillation\/Atrial Flutter<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #2: Etiology and Initial Investigations<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #1: Implementing GRADE and Achieving Consensus<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #3: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #8: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #7: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #4: Rate and Rhythm Management<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2010<\/td>Atrial Fibrillation Guidelines 2010 Update #6: Surgical Therapy<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Cardiac Computed Tomography<\/td>2010<\/td>Consensus Training Standards for Cardiac Computed Tomography<\/a><\/td>Training and MOC<\/td> <\/td><\/tr>
Cardiac Electrophysiology<\/td>2010<\/td>Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology<\/a><\/td>Training and MOC<\/td> <\/td><\/tr>
Cardiac Electrophysiology<\/td>2010<\/td>Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Heart Failure<\/td>2010<\/td>Heart Failure Guidelines 2010 Update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement\/assurance programs<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Interventional Cardiology<\/td>2010<\/td>Guidelines for Training and Maintenance of Competency in Adult Interventional Cardiology<\/a><\/td>Training and MOC<\/td> <\/td><\/tr>
Angina<\/td>2009<\/td>Refractory angina pectoris<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Antiplatelet Therapy<\/td>2009<\/td>Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
CAD\/ACS<\/td>2009<\/td>Management of ST elevation myocardial infarction: American College of Cardiology and American Heart Association 2004 Guidelines<\/a><\/td>Canadian Perspective<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2009<\/td>Dyslipidemia Guidelines 2009 Update: Diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult<\/a><\/td>Guideline<\/td> <\/td><\/tr>
Heart Disease<\/td>2009<\/td>Adult Congenital Heart Disease Guidelines Update 2009: Management of Adults with Congenital Heart Disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Heart Failure<\/td>2009<\/td>Heart Failure Guidelines 2009 Update: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2009<\/td>Cardiac computed tomography in 2009, \u2018What, when, where, who and how?\u2019, Guidelines for the clinician<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Paediatric Cardiology<\/td>2009<\/td>Cardiac risk assessment before the use of stimulant medications in children and youth – A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Transplantation<\/td>2009<\/td>Cardiac Transplantation<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2008<\/td>Endocarditis prophylaxis guidelines: A compromise between science and common sense:American Heart Association 2007 Guidelines<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Heart Failure<\/td>2008<\/td>Heart Failure Guidelines 2008 Update: Best practices for transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2008<\/td>Contrast Echocardiography: Putting things into perspective – A Canadian Cardiovascular Society\/Canadian Society of Echocardiography joint commentary<\/a><\/td>Canadian Perspective<\/td> <\/td><\/tr>
CAD\/ACS<\/td>2007<\/td>Drug-eluting stents – A Canadian Association of Interventional Cardiology and Canadian Cardiovascular Society joint statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Heart Failure<\/td>2007<\/td>Heart Failure Guidelines 2007 Update: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2007<\/td>Contrast Echocardiography in Canada – A Canadian Cardiovascular Society\/Canadian Society of Echocardiography Position Paper<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Dyslipidemia<\/td>2006<\/td>Diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Heart Failure<\/td>2006<\/td>Heart Failure Guidelines 2006: Diagnosis and management<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2006<\/td>Advanced Non-invasive Cardiac Imaging using Positron Emission Tomography, Magnetic Resonance Imaging and Multi-Detector Computed Tomographic Angiography in the Diagnosis and Evaluation of Ischemic Heart Disease – A joint position statement by CCS \/ CAR \/ CANM \/ CNCS \/ Can SCMR<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Device Therapy<\/td>2005<\/td>Implantable Cardioverter Defibrillator Use in Canada – A Canadian Cardiovascular Society and Canadian Heart Rhythm Society position paper<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Peripheral Arterial Disease<\/td>2005<\/td>Peripheral Arterial Disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Prevention \/ Risk<\/td>2005<\/td>Pulmonary Arterial Hypertension – A Canadian Cardiovascular Society and Canadian Thoracic Society position statement<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Atrial Fibrillation<\/td>2004<\/td>Atrial Fibrillation Guidelines 2004<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
CAD\/ACS<\/td>2004<\/td>STEMI: ACC\/AHA Guidelines<\/a><\/td>Canadian Perspective<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2004<\/td>Surgical Management of Valvular Heart Disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Imaging \/ Echo<\/td>2004<\/td>Provision of Echocardiography in Canada<\/a><\/td>Standards of Practice<\/td> <\/td><\/tr>
Transplantation<\/td>2004<\/td>Paediatric and Adult Congential Heart Transplantation<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Assessment to Drive\/Fly<\/td>2003<\/td>Fitness to Drive and Fly Guidelines 2003: Assessment of the cardiac patient for fitness to drive and fly 
<\/a>(Executive Summary<\/a>)<\/td>		Consensus Conference<\/td> <\/td><\/tr>
Heart Failure<\/td>2003<\/td>Heart Failure Guidelines 2002\/2003: Diagnosis and Management of Heart Failure<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2002<\/td>Management of Heart Disease in the Elderly Patient<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Prevention \/ Risk<\/td>2002<\/td>Hormone Replacement Therapy and Cardiovascular Disease –  Heart and Stroke Foundation of Canada, Society of Obstetricians and Gynecologists of Canada, Canadian Cardiovascular Society<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Heart Disease<\/td>2001<\/td>Adult Congenital Heart Disease Guidelines 2001: Management of Adults with Congenital Heart Disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Transplantation<\/td>2001<\/td>Cardiac Transplantation<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>2000<\/td>Women and ischemic heart disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Prevention \/ Risk<\/td>2000<\/td>Homocyst(e)ine and Cardiovascular Disease –  Heart and Stroke Foundation of Canada<\/a><\/td>Commentary<\/td> <\/td><\/tr>
Arrhythmia<\/td>1999<\/td>Prevention of sudden death from ventricular arrhythmia<\/a>  
(Executive Summary)<\/a><\/td>		Consenus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>1999<\/td>Sildenafil in the Management of Sexual Dysfunction in Patients with Cardiovascular Disease<\/a><\/td>Position Statement<\/td> <\/td><\/tr>
Prevention \/ Risk<\/td>1998<\/td>Prevention of cardiovascular diseases: the role of the cardiovascular specialist<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>1997<\/td>Evaluation and Management of Chronic Ischemic Heart Disease<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>1995<\/td>Indications For and Access To Revascularization<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Cardiovascular\/Heart Disease<\/td>1992<\/td>Coronary Thrombolysis<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr>
Angina<\/td>1976<\/td>Angina pectoris, a CCS Grading Scale<\/a><\/td>Consensus Conference<\/td> <\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"

These statements were developed following a thorough consideration of medical literature and the best available evidence and clinical experience. They represent the consensus of a multidisciplinary panel comprised of experts on the topic with a mandate to formulate disease-specific recommendations. Recommendations are aimed to provide a reasonable and practical approach to care for specialists and […]<\/p>\n","protected":false},"author":7813,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"footnotes":""},"wf_page_folders":[171],"acf":[],"yoast_head":"\nGuidelines and Clinical Practice Update Library - Canadian Cardiovascular Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines and Clinical Practice Update Library - Canadian Cardiovascular Society\" \/>\n<meta property=\"og:description\" content=\"These statements were developed following a thorough consideration of medical literature and the best available evidence and clinical experience. They represent the consensus of a multidisciplinary panel comprised of experts on the topic with a mandate to formulate disease-specific recommendations. Recommendations are aimed to provide a reasonable and practical approach to care for specialists and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Cardiovascular Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-15T22:00:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@SCC_CCS\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/\",\"url\":\"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/\",\"name\":\"Guidelines and Clinical Practice Update Library - Canadian Cardiovascular Society\",\"isPartOf\":{\"@id\":\"https:\/\/ccs.ca\/#website\"},\"datePublished\":\"2020-11-30T11:56:35+00:00\",\"dateModified\":\"2024-02-15T22:00:52+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccs.ca\/#website\",\"url\":\"https:\/\/ccs.ca\/\",\"name\":\"Canadian Cardiovascular Society\",\"description\":\"Strong heart teams in a heart-healthy Canada.\",\"publisher\":{\"@id\":\"https:\/\/ccs.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccs.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccs.ca\/#organization\",\"name\":\"Canadian Cardiovascular Society\",\"url\":\"https:\/\/ccs.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"contentUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"width\":699,\"height\":250,\"caption\":\"Canadian Cardiovascular Society\"},\"image\":{\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\",\"https:\/\/x.com\/SCC_CCS\",\"https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines and Clinical Practice Update Library - Canadian Cardiovascular Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/","og_locale":"en_US","og_type":"article","og_title":"Guidelines and Clinical Practice Update Library - Canadian Cardiovascular Society","og_description":"These statements were developed following a thorough consideration of medical literature and the best available evidence and clinical experience. They represent the consensus of a multidisciplinary panel comprised of experts on the topic with a mandate to formulate disease-specific recommendations. Recommendations are aimed to provide a reasonable and practical approach to care for specialists and […]","og_url":"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/","og_site_name":"Canadian Cardiovascular Society","article_publisher":"https:\/\/www.facebook.com\/SCC.CCS.ca\/","article_modified_time":"2024-02-15T22:00:52+00:00","twitter_card":"summary_large_image","twitter_site":"@SCC_CCS","twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/","url":"https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/","name":"Guidelines and Clinical Practice Update Library - Canadian Cardiovascular Society","isPartOf":{"@id":"https:\/\/ccs.ca\/#website"},"datePublished":"2020-11-30T11:56:35+00:00","dateModified":"2024-02-15T22:00:52+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccs.ca\/guidelines-and-clinical-practice-update-library\/"]}]},{"@type":"WebSite","@id":"https:\/\/ccs.ca\/#website","url":"https:\/\/ccs.ca\/","name":"Canadian Cardiovascular Society","description":"Strong heart teams in a heart-healthy Canada.","publisher":{"@id":"https:\/\/ccs.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccs.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ccs.ca\/#organization","name":"Canadian Cardiovascular Society","url":"https:\/\/ccs.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/","url":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","contentUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","width":699,"height":250,"caption":"Canadian Cardiovascular Society"},"image":{"@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCC.CCS.ca\/","https:\/\/x.com\/SCC_CCS","https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society"]}]}},"_links":{"self":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/115022"}],"collection":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/users\/7813"}],"replies":[{"embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/comments?post=115022"}],"version-history":[{"count":81,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/115022\/revisions"}],"predecessor-version":[{"id":134158,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/pages\/115022\/revisions\/134158"}],"wp:attachment":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/media?parent=115022"}],"wp:term":[{"taxonomy":"wf_page_folders","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/wf_page_folders?post=115022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}